Sec. 4. As used in this chapter, "gender transition hormone therapy" means: (1) testosterone; (2) estrogen; or (3) progesterone; given to an individual in an amount greater than would normally be produced endogenously in a healthy individual of that individual's age and sex. As added by P.L.10-2023, SEC.1.